http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105079776-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-69 |
| filingDate | 2015-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105079776-B |
| titleOfInvention | A kind of medicinal usage of lycorine and bortezomib composition |
| abstract | It is the pharmaceutical preparation that treatment Huppert's disease is used to prepare with lycorine and bortezomib composition the invention discloses the new medicine use of a kind of lycorine and bortezomib composition.The present invention is applied alone to have than the two using the combination of both lycorine and bortezomib preferably inhibits cel l proliferation, and combination can inhibit cell autophagy.The composition substantially increases sensibility of the Huppert's disease to bortezomib, is suitable for the Huppert's disease that refractory is treated. |
| priorityDate | 2015-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 209.